11/06/2026
Brain light therapy starts at the cellular level.
Transcranial photobiomodulation (tPBM) uses red or near-infrared light. One leading proposed mechanism involves cytochrome c oxidase, an enzyme in the mitochondrial respiratory chain.
Light may help release inhibitory nitric oxide, potentially supporting oxygen use and ATP production.
But dose matters. Wavelength, power, exposure time and treatment schedule can all affect the response.
More light is not automatically better.
Understanding the mechanism is only the beginning. Whether a treatment improves a particular condition must be evaluated in clinical studies. (Hennessy and Hamblin, 2017; Zhao et al., 2024.)
Educational content.
Not medical advice.